Stephen M Setter

Summary

Affiliation: College of Pharmacy
Country: USA

Publications

  1. ncbi The Mini-Cog: a rapid dementia screening tool suitable for pharmacists' use
    Stephen M Setter
    Department of Pharmacotherapy, Colleg eof Pharmacy, Washington State University Elder Services, Spokane, Washington 99217 6131, USA
    Consult Pharm 22:855-61. 2007
  2. ncbi Phosphodiesterase 5 inhibitors for erectile dysfunction
    Stephen M Setter
    Department of Pharmacotherapy, College of Pharmacy, Washington State University Elder Services, Spokane, WA 99217 6131, USA
    Ann Pharmacother 39:1286-95. 2005
  3. ncbi Treatment of chorea associated with Huntington's disease: focus on tetrabenazine
    Stephen M Setter
    Washington State University Elder Sevices, Spokane, Washington 99217, USA
    Consult Pharm 24:524-37. 2009
  4. doi Assessing the impact of ease of administration and tolerability on treatment choices in Parkinson's disease
    Stephen M Setter
    Department of Pharmacotherapy, College of Pharmacy, Washington State University, Elder Services Visiting Nurses Association, 5125 North Market Street, Spokane, WA 99217 6131, USA
    Neurol Clin 26:S45-63, vi. 2008
  5. doi Effectiveness of a pharmacist-nurse intervention on resolving medication discrepancies for patients transitioning from hospital to home health care
    Stephen M Setter
    Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, WA 99217, USA
    Am J Health Syst Pharm 66:2027-31. 2009
  6. ncbi Screening for undiagnosed cognitive impairment in homebound older adults
    Stephen M Setter
    Department of Pharmacotherapy, College of Pharmacy, Washington State University Elder Services, Spokane, Washington 99217 6131, USA
    Consult Pharm 24:299-305. 2009
  7. ncbi Inhaled dry powder insulin for the treatment of diabetes mellitus
    Stephen M Setter
    Department of Pharmacotherapy, College o f Pharmacy, Washington State University, Spokane, WA 99217 6131, USA
    Clin Ther 29:795-813. 2007
  8. doi Transitional care: exploring the home healthcare nurse's role in medication management
    Stephen M Setter
    Department of Pharmacotherapy, College of Pharmacy, Washington State University, Elder Services, Spokane, Washington 99217 6131, USA
    Home Healthc Nurse 30:19-26. 2012
  9. ncbi A survey of the perceptions, knowledge, and use of A1C values by home care patients and nurses
    Stephen M Setter
    Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, Washington, USA
    Diabetes Educ 29:144-52. 2003
  10. ncbi Biochemical pathways for microvascular complications of diabetes mellitus
    Stephen M Setter
    Department of Pharmacotherapy, College of Pharmacy, Washington State University Elder Services, Spokane, WA, USA
    Ann Pharmacother 37:1858-66. 2003

Detail Information

Publications32

  1. ncbi The Mini-Cog: a rapid dementia screening tool suitable for pharmacists' use
    Stephen M Setter
    Department of Pharmacotherapy, Colleg eof Pharmacy, Washington State University Elder Services, Spokane, Washington 99217 6131, USA
    Consult Pharm 22:855-61. 2007
    ..To familiarize the consultant pharmacist with the use of the Mini-Cog as a rapid screening tool for the assessment of dementia and outline currently available evidence regarding the validity of this screening tool within the community...
  2. ncbi Phosphodiesterase 5 inhibitors for erectile dysfunction
    Stephen M Setter
    Department of Pharmacotherapy, College of Pharmacy, Washington State University Elder Services, Spokane, WA 99217 6131, USA
    Ann Pharmacother 39:1286-95. 2005
    ..To review the pharmacologic and clinical trial data of the Food and Drug Administration-approved phosphodiesterase 5 (PDE5) inhibitors for the treatment of erectile dysfunction (ED)...
  3. ncbi Treatment of chorea associated with Huntington's disease: focus on tetrabenazine
    Stephen M Setter
    Washington State University Elder Sevices, Spokane, Washington 99217, USA
    Consult Pharm 24:524-37. 2009
    ..Review Huntington's disease (HD) and the role of tetrabenazine (TBZ) in treating chorea associated with this disease. Discuss the pharmacology, side-effect profile, drug interactions, precautions, and contraindications of TBZ...
  4. doi Assessing the impact of ease of administration and tolerability on treatment choices in Parkinson's disease
    Stephen M Setter
    Department of Pharmacotherapy, College of Pharmacy, Washington State University, Elder Services Visiting Nurses Association, 5125 North Market Street, Spokane, WA 99217 6131, USA
    Neurol Clin 26:S45-63, vi. 2008
    ..When prescribing antiparkinsonian therapies, the clinician should consider ease of administration, tolerability, and efficacy, along with other factors that are likely to contribute to optimal compliance by the patient...
  5. doi Effectiveness of a pharmacist-nurse intervention on resolving medication discrepancies for patients transitioning from hospital to home health care
    Stephen M Setter
    Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, WA 99217, USA
    Am J Health Syst Pharm 66:2027-31. 2009
    ..The effectiveness of a collaborative pharmacist-nurse intervention on resolving detected medication discrepancies as patients transitioned from hospital to home health care was evaluated...
  6. ncbi Screening for undiagnosed cognitive impairment in homebound older adults
    Stephen M Setter
    Department of Pharmacotherapy, College of Pharmacy, Washington State University Elder Services, Spokane, Washington 99217 6131, USA
    Consult Pharm 24:299-305. 2009
    ..To screen for undetected cognitive impairment in homebound elders receiving home health care services...
  7. ncbi Inhaled dry powder insulin for the treatment of diabetes mellitus
    Stephen M Setter
    Department of Pharmacotherapy, College o f Pharmacy, Washington State University, Spokane, WA 99217 6131, USA
    Clin Ther 29:795-813. 2007
    ..Inhaled dry powder insulin (IDPI) is the first inhaled insulin approved for the treatment of type 1 and type 2 diabetes mellitus (DM)...
  8. doi Transitional care: exploring the home healthcare nurse's role in medication management
    Stephen M Setter
    Department of Pharmacotherapy, College of Pharmacy, Washington State University, Elder Services, Spokane, Washington 99217 6131, USA
    Home Healthc Nurse 30:19-26. 2012
    ..Nurses must partner with pharmacists, physicians, and others involved with care transitions to decrease the likelihood of patients experiencing untoward health consequences associated with medications.-Eric A. ...
  9. ncbi A survey of the perceptions, knowledge, and use of A1C values by home care patients and nurses
    Stephen M Setter
    Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, Washington, USA
    Diabetes Educ 29:144-52. 2003
    ..The purpose of this study was to provide baseline information on the perceptions, use, and knowledge of hemoglobin A1C (A1C) values among home healthcare nurses and patients...
  10. ncbi Biochemical pathways for microvascular complications of diabetes mellitus
    Stephen M Setter
    Department of Pharmacotherapy, College of Pharmacy, Washington State University Elder Services, Spokane, WA, USA
    Ann Pharmacother 37:1858-66. 2003
    ..To review the current biochemical theories on how diabetes contributes to microvascular disease...
  11. ncbi Metformin hydrochloride in the treatment of type 2 diabetes mellitus: a clinical review with a focus on dual therapy
    Stephen M Setter
    Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane 99217 6131, USA
    Clin Ther 25:2991-3026. 2003
    ....
  12. ncbi Update in the pharmacologic treatment of diabetes: focus on insulin detemir, insulin glulisine, and inhaled dry powdered insulin
    Jason L Iltz
    Department of Pharmacotherapy, College of Pharmacy, Washington State University, PO Box 1495, Spokane, WA 99210 1495, USA
    Diabetes Educ 33:215-6, 220, 223-4 passim. 2007
    ..A detailed patient case designed to acquaint the reader with these newer insulin products and provide an understanding of clinical issues to consider when providing diabetes education to patients is included...
  13. doi Colesevelam hydrochloride for the treatment of type 2 diabetes mellitus
    Travis E Sonnett
    Department of Pharmacotherapy, College of Pharmacy, Washington State University, Pullman, Washington 99164 6510, USA
    Clin Ther 31:245-59. 2009
    ....
  14. ncbi Exenatide: an incretin mimetic for the treatment of type 2 diabetes mellitus
    Jason L Iltz
    Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, 99210 1495, USA
    Clin Ther 28:652-65. 2006
    ....
  15. ncbi Pharmacological management of glycemic control in the geriatric patient with type 2 diabetes mellitus
    Joshua J Neumiller
    Department of Pharmacotherapy, College of Pharmacy, Washington State University Elderly Services, Spokane, Washington 99217 6131, USA
    Consult Pharm 24:45-63. 2009
    ....
  16. doi Point-of-care screening to identify cognitive impairment in older adults
    Travis E Sonnett
    College of Pharmacy, Washington State University, P O Box 646510, Pullman, WA 99164 6510, USA
    J Am Pharm Assoc (2003) 52:492-7. 2012
    ....
  17. doi Review of linagliptin for the treatment of type 2 diabetes mellitus
    Joshua J Neumiller
    Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, 99210 1495, USA
    Clin Ther 34:993-1005. 2012
    ....
  18. doi Nurse identified hospital to home medication discrepancies: implications for improving transitional care
    Cynthia F Corbett
    College of Nursing, Washington State University, Spokane, WA, USA
    Geriatr Nurs 31:188-96. 2010
    ..Medication discrepancies were identified in virtually all classes of medications, including those with high safety risks. Evidence-based best practices to reduce transition-related medication discrepancies are presented...
  19. doi Looking to the future: focus on DPP-4 inhibitors for the treatment of type 2 diabetes and emerging therapies
    Joshua J Neumiller
    PharmD, Department of Pharmacotherapy, College of Pharmacy, Washington State University Elder Services, 5125 North Market Street, Spokane, WA 99217, USA
    Diabetes Educ 34:183-200. 2008
    ..This article, part 3 of a 3-part series, reviews the new class of medications known as DPP-4 inhibitors as well as discusses a future buccal insulin formulation, Oral-Lyn, on the horizon for the treatment of diabetes mellitus...
  20. doi Clinical review of treatment options for select nonmotor symptoms of Parkinson's disease
    Lindy D Wood
    Elder Services, Spokane, Washington, USA
    Am J Geriatr Pharmacother 8:294-315. 2010
    ..The nonmotor symptoms of PD have the potential to be more debilitating than the motor features of the disorder...
  21. pmc Pharmacology, efficacy and safety of liraglutide in the management of type 2 diabetes
    Joshua J Neumiller
    Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, Washington
    Diabetes Metab Syndr Obes 3:215-26. 2010
    ..Diligent postmarketing surveillance to elucidate the risk of pancreatitis and medullary thyroid carcinoma in a heterogeneous population are likely warranted...
  22. doi Pharmacologic management of the older patient with type 2 diabetes mellitus
    Joshua J Neumiller
    Department of Pharmacotherapy, College of Pharmacy, Washington State University Elder Services, Spokane, Washington 99217 6131, USA
    Am J Geriatr Pharmacother 7:324-42. 2009
    ....
  23. ncbi OASIS and beyond: improving outcomes for home health patients
    Cynthia F Corbett
    Intercollegiate College of Nursing, Washington State University, 2715 West Fort George Wright Drive, Spokane, WA 99224, USA
    Diabetes Educ 29:83-9. 2003
  24. doi Rate of obesity in U.S. ambulatory patients with diabetes mellitus: a national assessment of office-based physician visits
    Joshua J Neumiller
    Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, WA 99217, United States
    Prim Care Diabetes 3:197-9. 2009
    ..S. National Ambulatory Medical Care Survey (NAMCS). Our findings indicate a significant proportion of U.S. ambulatory patients with DM present with obesity and greater clinical acuity than patients with DM alone...
  25. ncbi Pregabalin for the treatment of painful neuropathy
    Travis E Sonnett
    Washington State University, College of Pharmacy, Family Home Care Corporation, 9922 E Montgomery Avenue, Suite 3, Spokane, WA 99206, USA
    Expert Rev Neurother 6:1629-35. 2006
    ..This article will review each of these studies, as well as provide a clinical review for the use of pregabalin in the treatment of neuropathic pain...
  26. doi Exploring the concept of medication discrepancy within the context of patient safety to improve population health
    Catherine R Murphy
    Pullman Regional Hospital, Pullman, Washington, USA
    ANS Adv Nurs Sci 32:338-50. 2009
    ..Conceptual clarity about the various aspects of medication discrepancy in the context of patient safety has the potential to enhance quality improvement efforts and patient outcomes to improve population health...
  27. ncbi Meloxicam: a reappraisal of pharmacokinetics, efficacy and safety
    Brian J Gates
    College of Pharmacy, Department of Pharmaceutical Sciences, Washington State University, Pullman, Washington 99164 6534, USA
    Expert Opin Pharmacother 6:2117-40. 2005
    ..The pharmacokinetics of meloxicam enables once daily application, which increases compliance compared with some shorter acting NSAIDs; however, long-term clinical data clearly demonstrating safety and efficacy advantages are lacking...
  28. pmc Type 2 translational research for CKD
    Katherine R Tuttle
    Providence Medical Research Center, Providence Sacred Heart Medical Center and Children s Hospital, Spokane, Washington, Nephrology Division, Department of Medicine, University of Washington School of Medicine, Seattle, Washington, Division of Nephrology and, Department of Medicine, University of California San Francisco, San Francisco, California, College of Nursing and, College of Pharmacy, Washington State University, Spokane, Washington
    Clin J Am Soc Nephrol 8:1829-38. 2013
    ..Focus on the theory, framework, and approaches we have suggested may help us meet that challenge. ..
  29. ncbi Tigecycline: an investigational glycylcycline antimicrobial with activity against resistant gram-positive organisms
    Mark W Garrison
    Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, Washington 99210 1495, USA
    Clin Ther 27:12-22. 2005
    ..Tigecycline is an investigational glycylcycline antibiotic that shows promising activity against these resistant gram-positive organisms...
  30. ncbi Update in the pharmacologic treatment of diabetes mellitus: focus on pramlintide and exenatide
    Peggy Soule Odegard
    Geriatrics Program, School of Pharmacy, University of Washington, Box 357630, 1959 NE Pacific Street, Seattle, WA 98195, USA
    Diabetes Educ 32:693-712. 2006
    ..Cases will be used to assist with understanding the type of patient who will benefit from each of these new therapies...
  31. ncbi Diabetic neuropathy: an intensive review
    Jeremiah John Duby
    University of Arizona, Tucson, AZ, USA
    Am J Health Syst Pharm 61:160-73; quiz 175-6. 2004
    ..The epidemiology, classification, pathology, and treatment of diabetic neuropathy are reviewed...
  32. ncbi The use of anticholinergic medications in homebound elderly patients with dementia
    Wen Yi Chan
    Centre for Socioeconomic Research, Welsh School of Pharmacy, Cardiff University, Wales, UK
    Consult Pharm 21:391-9. 2006
    ..Compare the use of anticholinergic medications in older adults with a diagnosis of dementia to a matched comparison group without a diagnosis of dementia...